市場調查報告書
商品編碼
1403432
2030 年預充式注射器市場預測:按類型、材料、設計、配銷通路、應用和地區進行的全球分析Prefilled Syringes Market Forecasts to 2030 - Global Analysis By Type, By Material, Design, Distribution Channel, Application and By Geography |
根據 Stratistics MRC 的數據,2023 年全球預充式注射器市場規模為 81.5 億美元,預計在預測期內將以 12.9% 的複合年成長率成長,到 2030 年達到 190.5 億美元。
預充式注射器是即用型醫療設備,含有預先量好的藥物,經過密封和消毒,用於一次性注射。它由筒體、柱塞、針頭組成,給藥方便、準確、安全。透過降低給藥錯誤和污染的風險並簡化醫療程序,預充式注射器可以滿足從疫苗和生技藥品到慢性病管理和緊急護理等各種治療中的不同醫療需求。
日內瓦協會發布的報告估計,在過去二十年中,全球醫療保健支出佔 GDP 的比例已從約 8% 增加到近 10%,每年估計達 8 兆美元。
慢性病增加
糖尿病、自體免疫疾病和各種神經系統疾病等慢性病發病率的上升正在推動預充式注射器市場的發展。這些疾病需要定期和精確的劑量,增加了對使用者友好和準確的藥物傳輸系統(如預充式注射器)的需求。預充式注射器方便、給藥準確,並降低了污染和給藥錯誤的風險,滿足了需要頻繁給藥的患者的需求。此外,慢性病盛行率的上升正促使醫療保健提供者擴大選擇高效、隨時給藥的解決方案來加強患者護理和這些疾病的管理,市場的成長軌跡凸顯。
注射量限制
雖然這些注射器為許多藥物提供了方便和精確的給藥,但它們通常具有固定或有限的注射量。這種限制影響某些需要大給藥或給藥變化的藥物。對於超出注射器容量的藥物,必須考慮替代的輸送系統,限制了預充式注射器對所有類型藥物的普遍適用性。這種適應不同給藥要求的限制限制了預充式注射器在某些治療領域的普及,並影響了市場滲透率。
擴大新興市場的醫療保健基礎設施
新興市場醫療保健基礎設施的擴張為預充式注射器市場帶來了巨大的機會。這些地區的醫療保健設施顯著增加,增加了對高效且具成本效益的藥物輸送系統的需求。此外,在資源有限的環境中簡化給藥和儲存的潛力增加了其吸引力,推動了新興經濟體快速成長的醫療基礎設施的採用和市場擴張。
嚴格的監管要求和核准流程
嚴格的監管要求和核准流程對預充式注射器市場構成重大威脅。需要遵守複雜的監管標準,特別是在材料相容性、製造標準和無菌保證方面,延長了產品開發和市場進入所需的時間和資源。合規性挑戰可能會導致核准延遲、開發成本增加和創新受限。這些嚴格的法規為新進入者設置了障礙,影響市場競爭力並阻礙市場成長。
COVID-19 大流行對預充式注射器市場產生了重大影響。隨著世界各地疫苗接種宣傳活動變得緊迫,對有效給藥疫苗的預充式注射器的需求不斷增加。製造商面臨增加產量以滿足全球疫苗分銷要求的挑戰,導致供應鏈挑戰和原料競爭加劇。此外,嚴格的安全措施、監管調整以及對大規模疫苗接種宣傳活動的關注正在加速預充式注射器技術的創新和投資,以確保安全、高效和可擴展的疫苗輸送解決方案。
預計玻璃領域在預測期內將成為最大的領域
在預充式注射器中,玻璃部分預計將佔據最大的市場佔有率。玻璃具有化學惰性等卓越品質,可確保穩定性以及與多種藥物的相容性。其透明度有利於目視檢查,這對於藥物完整性至關重要。隨著對生技藥品和敏感藥品的需求不斷增加,玻璃的防潮和氣體阻隔性能成為首選。此外,對藥物交互作用的日益擔憂以及對精確藥物輸送的需求正在推動人們對玻璃的偏好,從而鞏固了其在預充式注射器市場的主導地位。
網路商店領域預計在預測期內複合年成長率最高
由於醫療保健領域電子商務的崛起趨勢,網路商店領域預計將在預充式注射器市場中呈現最高成長率。線上平台為消費者提供便利、可近性和廣泛的產品。隨著數位平台的日益普及,患者和醫療保健提供者更喜歡線上訂購醫療用品的便利性。隨著世界向數位化的轉變以及對非接觸式交易的日益重視,預計預灌封注射器市場的網路商店將快速成長。
由於其強大的醫療基礎設施、對先進醫療技術的高度認知以及對注射藥物需求的快速成長,北美預計將佔據預充式注射器市場的最大佔有率。該地區擁有成熟的製藥業,加上在研發方面的大量投資,使其成為預充式注射器的主要市場。此外,對以患者為中心的藥物輸送的日益關注進一步推動了預充式注射器的採用,有助於鞏固北美市場的主導地位。
亞太地區預充式注射器市場的強勁成長歸因於該地區醫療基礎設施的不斷擴大、藥品投資的增加以及對患者安全的日益重視。不斷成長的醫療保健支出、龐大的患者群體以及政府推廣先進醫療保健技術的舉措正在推動對預充式注射器的需求。此外,該地區的免疫計劃,加上慢性病的迅速增加,正在推動預充式注射器的採用。
According to Stratistics MRC, the Global Prefilled Syringes Market is accounted for $8.15 billion in 2023 and is expected to reach $19.05 billion by 2030 growing at a CAGR of 12.9% during the forecast period. Prefilled syringes are ready-to-use medical devices containing a premeasured dose of medication, sealed and sterilized for single-use injection. Comprising a barrel, plunger and needle, they offer convenience, accuracy, and safety in drug administration. Prefilled syringes reduce dosing errors, contamination risks and streamline medical procedures, catering to diverse healthcare needs across various treatments, from vaccines and biologics to chronic disease management and emergency medicine.
According to a report published by Geneva Association, in the last two decades, the share of total aggregate global expenditure on healthcare in GDP has increased from about 8% to almost 10%, or an estimated USD 8 trillion per annum.
The escalating incidence of chronic illnesses, such as diabetes, autoimmune disorders, and various neurological conditions, has propelled the prefilled syringes market. These conditions require regular and precise medication dosages, fostering the demand for user-friendly, accurate drug delivery systems like prefilled syringes. Offering convenience, dosage accuracy and reduced risks of contamination or dosage errors, prefilled syringes address the needs of patients requiring frequent medication. Additionally, this rising prevalence of chronic diseases emphasizes the market's growth trajectory as healthcare providers increasingly opt for efficient, ready-to-administer solutions to enhance patient care and management of these conditions.
These syringes offer convenience and accurate dosing for many medications, they often come with fixed or limited injection volumes. This constraint affects certain drugs requiring larger doses or those with variable dosage needs. For medications that exceed the syringe's volume capacity, alternative delivery systems must be considered, limiting the universal applicability of prefilled syringes across all medication types. This limitation in accommodating diverse dosage requirements restrains their widespread adoption in certain therapeutic areas, impacting their market penetration.
The expanding healthcare infrastructure in emerging markets presents a significant opportunity for the prefilled syringes market. As these regions witness substantial growth in medical facilities, there's a heightened demand for efficient and cost-effective drug delivery systems. Additionally, their potential for streamlined administration and storage in resource-limited settings enhances their attractiveness, driving their adoption and market expansion within burgeoning healthcare infrastructures across emerging economies.
Stringent regulatory requirements and approval processes pose a significant threat to the prefilled syringes market. The need to adhere to complex regulatory standards, especially regarding material compatibility, manufacturing standards and sterility assurance, prolongs the time and resources required for product development and market entry. Compliance challenges may lead to delays in approvals, increasing development costs and potentially limiting innovation. These rigorous regulations create barriers for new entrants, impacting market competitiveness and hindering market growth.
The COVID-19 pandemic significantly impacted the prefilled syringes market. The urgent need for vaccination campaigns worldwide propelled demand for prefilled syringes to administer vaccines efficiently. Manufacturers faced increased production to meet global vaccine distribution requirements, leading to supply chain challenges and heightened competition for materials. Additionally, stringent safety measures, regulatory adaptations and the focus on mass vaccination campaigns accelerated innovation and investment in prefilled syringe technologies to ensure safe, efficient and scalable vaccine delivery solutions.
The glass segment is anticipated to secure the largest market share in prefilled syringes. Glass offers superior qualities such as chemical inertness, ensuring stability and compatibility with a wide range of medications. Its transparency enables easy visual inspection, which is crucial for drug integrity. With an increasing demand for biologics and sensitive formulations, glass's barrier properties against moisture and gases are preferred. Moreover, heightened concerns about drug interaction and the need for precise drug delivery amplify the preference for glass, solidifying its dominance in the prefilled syringes market.
The online store segment is expected to witness the highest growth rate in the prefilled syringes market due to the increasing trend of e-commerce in healthcare. Online platforms provide convenience, accessibility, and a wide product range for consumers. With the rising adoption of digital platforms, patients and healthcare providers prefer the ease of ordering medical supplies online. The ongoing global shift towards digitalization and emphasizing contactless transactions further drives the anticipated rapid growth of online stores in the prefilled syringes market.
North America is poised to secure the largest market share in prefilled syringes due to a robust healthcare infrastructure, high awareness of advanced medical technologies, and a surge in demand for injectable drugs. The region's well-established pharmaceutical industry, coupled with significant investments in research and development, positions it as a key market for prefilled syringes. Additionally, increased focus on patient-centric drug delivery further fuels the adoption of prefilled syringes, contributing to North America's dominant position in the market.
Asia Pacific's robust growth in the prefilled syringes market is attributed to the region's expanding healthcare infrastructure, rising investments in pharmaceuticals and a growing emphasis on patient safety. Increasing healthcare expenditure, a large patient population and government initiatives promoting advanced healthcare technologies drive the demand for prefilled syringes. Moreover, the region's escalating vaccination programs, coupled with the burgeoning prevalence of chronic diseases, bolster the adoption of prefilled syringes.
Some of the key players in prefilled syringes market include BD (Becton, Dickinson and Company), Catalent, Daikyo Seiko, Ltd., Gerresheimer, Haselmeier GmbH, Nemera, Nipro Corporation, Recipharm, SCHOTT AG, SHL Group, Stevanato Group, Terumo Corporation, Vaccinex, Inc., Vetter Pharma International GmbH, Weigao Group, West Pharmaceutical Services, Inc., Wuxi AppTec and Ypsomed.
In July 2023, KORU Medical Systems announced the 510(K) Submission for Freedom60® Infusion System with Hizentra® 50 mL Prefilled Syringes.
In May 2023, Nexus Pharmaceuticals announced the FDA approval of single-dose prefilled syringes for Emerphed® (ephedrine sulfate injection) used for the treatment of clinically important hypotension occurring in the setting of anesthesia.
In January 2022, Owen Mumford announced that it received approval for its UniSafe 1mL safety device for pre-filled syringes in Asia. In Europe, regulatory approval has also been granted for UniSafe 1mL, and the product is now available on the market as a combination product with a drug for the treatment of rheumatoid arthritis.